Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin
Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Tübingen, Germany.ORCID iD: 0000-0002-6716-8284
Show others and affiliations
2013 (English)In: Mucosal Immunology, ISSN 1933-0219, E-ISSN 1935-3456, Vol. 6, no 6, p. 1179-1190Article in journal (Refereed) Published
Abstract [en]

Human β-defensin 1 (hBD-1) is an antimicrobial peptide expressed by epithelia and hematopoietic cells. We demonstrated recently that hBD-1 shows activity against enteric commensals and Candida species only after its disulfide bonds have been reduced by thioredoxin (TRX) or a reducing environment. Here we show that besides TRX, glutaredoxin (GRX) is also able to reduce hBD-1, although with far less efficacy. Moreover, living intestinal and lymphoid cells can effectively catalyze reduction of extracellular hBD-1. By chemical inhibition of the TRX system or specific knockdown of TRX, we demonstrate that cell-mediated reduction is largely dependent on TRX. Quantitative PCR in intestinal tissues of healthy controls and inflammatory bowel disease patients revealed altered expression of some, although not all, redox enzymes, especially in ulcerative colitis. Reduced hBD-1 and TRX localize to extracellular colonic mucus, suggesting that secreted or membrane-bound TRX converts hBD-1 to a potent antimicrobial peptide in vivo.

Place, publisher, year, edition, pages
Nature Publishing Group, 2013. Vol. 6, no 6, p. 1179-1190
National Category
Natural Sciences Medical and Health Sciences
Identifiers
URN: urn:nbn:se:umu:diva-166027DOI: 10.1038/mi.2013.17ISI: 000325916800012PubMedID: 23571504OAI: oai:DiVA.org:umu-166027DiVA, id: diva2:1376352
Available from: 2019-12-09 Created: 2019-12-09 Last updated: 2019-12-11Bibliographically approved

Open Access in DiVA

fulltext(2430 kB)12 downloads
File information
File name FULLTEXT01.pdfFile size 2430 kBChecksum SHA-512
7e78205b2965aad9b4af73ff19e741ccf21e5b82a4ecb33374ade700e6a940f02739b6cd9b6b75a20d792a3314d960b35577b2e496fc3e4dd076074dd6fb07a7
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Schröder, Björn
In the same journal
Mucosal Immunology
Natural SciencesMedical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 12 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 16 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf